EUVIMEDEUVIMED entdecken
Open Access

Wait times between lung cancer diagnosis and surgery: national trends, disparities, and impact on long-term survival

Claire Perez iD, Andrew R Brownlee, Lucas Weiser, Justin J J Watson, Kellie Knabe, Charles Fuller, Shruthi Nammalwar, Qiudong Chen, Raffaele Rocco, Harmik J Soukiasian

Journal of Thoracic Disease · 2025-08 · 17 (8) · 5983-5992

DOI: 10.21037/jtd-2024-2002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Disease, 2025-08. Verfasst von Claire Perez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, Cedars Sinai Medical Center Los Angeles, CA, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The survival difference associated with delays between lung cancer diagnosis and definitive surgery is poorly defined in contemporary practice. The aim of this study was to evaluate the prevalence of treatment delays, trends in wait times, and survival impact in a national cohort.

Methods

All patients with stage I or II non-small cell lung cancer (NSCLC) undergoing anatomic resection in the U.S. from 2004 to 2018 were identified in the National Cancer Database (NCDB). The association between survival and the interval between diagnosis and surgery was evaluated. Cox regression, logistic regression, and propensity score matching were used to adjust for differences in patient characteristics.

Results

Between 2004-2018, 1,898,210 patients were diagnosed with lung cancer and 219,723 met the inclusion criteria. The median time between diagnosis and surgery was 30.5 [interquartile range (IQR), 5-50] days. The median wait time increased from 25 (IQR, 0-47) days in 2004 to 38 (IQR, 17-59) days in 2018 (P 4 and the other ≤4 weeks for surgery. The median age was 68 years and 45.7% [76,647] were men (P 4 weeks for definitive surgery compared with those waiting ≤4 weeks for stage I and II patients (P

Schlagwörter

Stichwörter der Autor:innen

Lung cancerdisparitiestreatment delayswait times

Autor:innen und Institutionen

  • Division of Thoracic Surgery, Department of Surgery, Cedars Sinai Medical Center Los Angeles, CA, USA.

ORCID-Profile: Claire Perez

Zitieren

APA

Perez, C., Brownlee, A. R., Weiser, L., Watson, J. J. J., Knabe, K., Fuller, C., Nammalwar, S., Chen, Q., Rocco, R., & Soukiasian, H. J. (2025). Wait times between lung cancer diagnosis and surgery: national trends, disparities, and impact on long-term survival. Journal of Thoracic Disease, 17(8), 5983-5992. https://doi.org/10.21037/jtd-2024-2002

Vancouver

Perez C, Brownlee AR, Weiser L, Watson JJJ, Knabe K, Fuller C, et al. Wait times between lung cancer diagnosis and surgery: national trends, disparities, and impact on long-term survival. Journal of Thoracic Disease. 2025;17(8):5983-5992. doi:10.21037/jtd-2024-2002

BibTeX
@article{Perez2025,
  author = {Perez, Claire and Brownlee, Andrew R and Weiser, Lucas and Watson, Justin J J and Knabe, Kellie and Fuller, Charles and Nammalwar, Shruthi and Chen, Qiudong and Rocco, Raffaele and Soukiasian, Harmik J},
  title = {Wait times between lung cancer diagnosis and surgery: national trends, disparities, and impact on long-term survival},
  journal = {Journal of Thoracic Disease},
  year = {2025},
  volume = {17},
  number = {8},
  pages = {5983--5992},
  doi = {10.21037/jtd-2024-2002}
}
Kostenlos starten →